FAMOTIDINE
NDC 68382-444, famotidine, powder, for suspension, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-444
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-444 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-444-05 | 68382044405 | 50 mL in 1 BOTTLE, PLASTIC (68382-444-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a8010e10-68fd-455f-968f-d62a1c3e0ffdNADAC price for package 68382044405
GET /v1/drugs/nadac/68382044405
Use it
Look up 68382-444 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-444 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-444. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.